FIRST FOUNDATION ADVISORS

Endowment

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1086763 Irvine, CA

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,903,044

-$454,280 QoQ

Shares Held

3,052

+0.0% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#524

of 1,322 holders

Holding Since

Dec 2020

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FIRST FOUNDATION ADVISORS holds $2,160,846 across 2 Biotechnology names. REGN ranks #1 (88.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	REGN	Regeneron Pharmaceuticals, Inc. This page	3,052	$1,903,044
2	VRTX	Vertex Pharmaceuticals Inc / Ma	519	$257,802

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,903,044	3,052	+0.0%	Shares	Sole	2026-08-14
2026-03-31	$2,357,324	3,051	+0.1%	Shares	Sole	2026-05-04
2025-12-31	$2,353,431	3,049	0.0%	Shares	Sole	2026-02-04
2025-09-30	$1,714,361	3,049	-0.1%	Shares	Sole	2025-11-17
2025-06-30	$1,602,825	3,053	-1.6%	Shares	Sole	2025-08-14
2025-03-31	$1,968,015	3,103	+0.1%	Shares	Sole	2025-05-08
2024-12-31	$2,207,510	3,099	-0.3%	Shares	Sole	2025-02-13
2024-09-30	$3,268,305	3,109	0.0%	Shares	Sole	2024-11-14
2024-06-30	$3,267,652	3,109	0.0%	Shares	Sole	2024-08-06
2024-03-31	$2,992,381	3,109	+1.6%	Shares	Sole	2024-05-10
2023-12-31	$2,686,689	3,059	-5.2%	Shares	Sole	2024-02-14
2023-09-30	$2,656,514	3,228	-0.0%	Shares	Sole	2023-11-15
2023-06-30	$2,320,165	3,229	-4.1%	Shares	Sole	2023-08-14
2023-03-31	$2,766,562	3,367	+2.0%	Shares	Sole	2023-05-12
2022-12-31	$2,381,638	3,301	+36.3%	Shares	Sole	2023-02-14
2021-09-30	$1,465,745	2,422	-13.5%	Shares	Defined	2021-11-15
2021-06-30	$1,563,353	2,799	+1.9%	Shares	Defined	2021-08-13
2021-03-31	$1,299,715	2,747	+137.4%	Shares	Sole	2021-05-18
2020-12-31	$558,957	1,157	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.